Ronald A Rittenmeyer Form 4 TENET HEALTHCARE / Ronald A Rittenmeyer ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Rittenmeyer Ronald A

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TX 75254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Executive Chairman and CEO

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2021

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	06/30/2021		M		62,908	A	(2)	746,772	D
Common Stock	06/30/2021		F		24,755(3)	D	$66.99	722,017	D
Common Stock(4)	06/30/2021		M		32,701	A	(2)	754,718	D
Common Stock	06/30/2021		F		12,868(3)	D	$66.99	741,850	D
Common Stock(5)	06/30/2021		M		23,652	A	(2)	765,502	D
Common Stock	06/30/2021		F		9,308(3)	D	$66.99	756,194	D
Common Stock								15,000	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
2019 February Restricted Stock Units	(1)	06/30/2021		M			62,908	(1)	(1)	Common Stock(6)	62,908	$0.00	0	D
2020 February Restricted Stock Units	(4)	06/30/2021		M			32,701	(4)	(4)	Common Stock(6)	32,701	$0.00	196,208	D
2021 February Restricted Stock Units	(5)	06/30/2021		M			23,652	(5)	(5)	Common Stock(6)	23,652	$0.00	141,912	D

Explanation of Responses:

1. As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The ninth vesting date occurred on June 30, 2021, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I.

2. Restricted stock units convert into common stock on a one-for-one basis.

3. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

4. As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The fifth vesting date occurred on June 30, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 196,208 restricted stock units are shown in Table II.

5. As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The second vesting date occurred on June 30, 2021, resulting in the vesting and settlement of 23,652 shares of common stock, as shown in Table I. The remaining 141,912 restricted stock units are shown in Table II.

6. Restricted stock units are settled in shares of the Company's common stock upon vesting.

Remarks:

	Mark R. Jackson, as Attorney-in-Fact for Ronald A. Rittenmeyer	07/02/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.